Sabien Technology Group PLC Admission of New Shares & Total Voting Rights

RNS Number : 9505C

Sabien Technology Group PLC

04 September 2024

 

4 September 2024

Sabien Technology Group plc

("Sabien" or the "Company" or the "Group")

 

Update on Admission of New Ordinary Shares

Total Voting Rights

 

Sabien (AIM: SNT), a leader in Green Aggregation Strategy, announced on 20 August 2024 the intention to allot 435,967 ordinary shares of 3 pence each in the Company ("Ordinary Shares") in settlement of £40,000 of broker fees (the "New Shares").  The Company confirms that following receipt of the outstanding documentation referred to in the announcement of 29 August 2024, an application has been made for the New Shares to be admitted to trading on AIM ("Admission") on 10 September 2024. 

 

Following Admission, the Company will have 23,631,135 Ordinary Shares in issue, each share carrying the right to one vote. The Company does not hold any Ordinary Shares in Treasury. Therefore, following Admission, the figure of 23,631,135 Ordinary Shares may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

 

For Further Information: Sabien Technology Group plc Richard Parris, Executive Chairman	[phone] [e-mail]
Allenby Capital Limited (Nominated Adviser) John Depasquale / Nick Harriss / Vivek Bhardwaj	[phone]
Peterhouse Capital Limited (Broker) Duncan Vasey / Lucy Williams	[phone]

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

IOEQKQBDABKDQCK